Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Placenta ; 32(12): 1026-32, 2011 Dec.
Article in English | MEDLINE | ID: mdl-22015023

ABSTRACT

Intrahepatic cholestasis of pregnancy (ICP) is a pregnancy specific liver disease associated with significant risk of fetal complications. It is hypothesised that the risk of adverse fetal outcomes relates to the toxic effects of bile acids, the levels of which are increased in both maternal and fetal serum. Human and rodent studies have shown that transplacental transfer of bile acids is impaired in ICP. Furthermore, the morphology of placentas from the rodent model of ICP is markedly abnormal, and is associated with increased expression of apoptotic markers and oxidative stress. Using placental tissue from ICP cases and normal pregnancies and cultured placental explant fragments we investigated the histological and molecular effects of cholestasis. We also examined the influence of ursodeoxycholic acid (UDCA) administration on these parameters. Here we report that ICP is associated with several morphological abnormalities of the placenta, including an increase in the number of syncytial knots, and that these can be reproduced in an in vitro (explant) model exposed to the bile acids taurocholic acid and taurochenodoexycholic acid. Furthermore, we demonstrate that ursodeoxycholic acid, a drug commonly used in the management of ICP, has a protective effect on placental tissue both in vivo and in vitro.


Subject(s)
Cholestasis, Intrahepatic/pathology , Placenta/pathology , Pregnancy Complications/pathology , Cholestasis, Intrahepatic/drug therapy , Female , Humans , Phenotype , Placenta/drug effects , Placenta/metabolism , Pregnancy , Pregnancy Complications/drug therapy , Taurochenodeoxycholic Acid/pharmacology , Taurocholic Acid/pharmacology , Ursodeoxycholic Acid/therapeutic use
2.
Placenta ; 32(7): 535-7, 2011 Jul.
Article in English | MEDLINE | ID: mdl-21596433

ABSTRACT

Bile acids are the toxic end products of hepatic cholesterol metabolism. They are synthesised from early in gestation and excreted via the placenta. The mechanism for transplacental excretion of bile acids is not known. The gene and protein expression of the nuclear receptors responsible for hepatic bile acid metabolism and transport was studied in eight normal and fourteen cholestatic placentas, and in an ex vivo model. The expression of the nuclear receptor FXR and several of it's target genes and of PXR and CAR was found to be very low in both normal and cholestatic placenta.


Subject(s)
ATP-Binding Cassette Transporters/biosynthesis , Cholestasis, Intrahepatic/metabolism , Placenta/metabolism , Pregnancy Complications/metabolism , Receptors, Cytoplasmic and Nuclear/biosynthesis , Receptors, Cytoplasmic and Nuclear/metabolism , Receptors, Steroid/metabolism , ATP Binding Cassette Transporter, Subfamily B, Member 11 , Bile Acids and Salts/metabolism , Constitutive Androstane Receptor , Female , Gene Expression , Humans , Liver/metabolism , Pregnancy , Pregnane X Receptor
SELECTION OF CITATIONS
SEARCH DETAIL
...